Axcan Helicide amendment
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Axcan submits Helicide amendment addressing manufacturing issues in response to "not approvable" letter from FDA, announced in August. An NDA for the H. pylori eradication agent (subcitrate/metronidazole/tetracycline) was submitted Sept. 30, 200